Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level.

Trump and his commerce secretary are threatening to make medications more expensive by slapping tariffs on them.

The logo of US pharmaceutical company Pfizer at the 7th China International ... a landmark agreement earlier this month to invest $2.5 billion in Beijing over the next five years, demonstrating ...

Tariff worries continue hanging over companies as they report their latest financial results and try to provide guidance on ...

France's Sanofi reported first-quarter profit that beat analysts' expectations on Thursday, boosted by strong demand for its anti-inflammatory drug Dupixent, as well as newer treatments and vaccines.

Apps: Pre-built applications with intuitive interfaces enable business users across the organization to leverage AI ...

(Reuters) -AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

The agreement is valued at over $3 billion and increases U.S. manufacturing capacity to help ensure patient access to ...

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt ...

Conduit Pharmaceuticals files next generation cocrystal patent for VTAMA ® (tapinarof) which the Company believes could be a superior asset with both inflammatory and autoimmune prospectives just ...

Vertex Pharmaceuticals (NASDAQ ... Could it catch up to its bigger biotech peer, and even become the next Vertex in the eyes of investors? Let's find out. Let's start by taking a look at the ...